Geron Corp. (GERN)
1.415
+0.02
(+1.07%)
USD |
NASDAQ |
May 13, 16:00
1.41
0.00 (0.00%)
After-Hours: 17:18
Geron Cash from Investing (Quarterly) : 51.86M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 536.82M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
| Insmed, Inc. | 265.52M |
| MannKind Corp. | 18.72M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -62.91M |
| Cash from Financing (Quarterly) | 2.425M |
| Free Cash Flow | -126.13M |
| Free Cash Flow Per Share (Quarterly) | -0.0944 |
| Free Cash Flow to Equity (Quarterly) | -63.42M |
| Free Cash Flow to Firm (Quarterly) | -56.01M |
| Free Cash Flow Yield | -13.35% |